3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine

C166H128N6 — CID 159066790

IUPAC3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine
SMILESCC1(C)c2ccccc2N(c2ccc(-c3ccccc3-c3ccccc3)cc2)c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc21.CC1(C)c2ccccc2N(c2ccc3c(c2)CCCc2ccccc2-3)c2ccc(-c3ccc(N(c4ccc5c(ccc6ccccc65)c4)c4ccc5c(ccc6ccccc65)c4)cc3)cc21.CC1(C)c2ccccc2N(c2ccccc2)c2ccc(-c3cccc(-c4cccc(N(c5ccccc5)c5ccc(-c6ccccc6)cc5)c4)c3)cc21
InChIInChI=1S/C64H48N2.2C51H40N2/c1-64(2)60-20-9-10-21-62(60)66(53-33-36-57-47(38-53)16-11-15-43-12-3-6-17-54(43)57)63-37-28-46(41-61(63)64)42-26-29-50(30-27-42)65(51-31-34-58-48(39-51)24-22-44-13-4-7-18-55(44)58)52-32-35-59-49(40-52)25-23-45-14-5-8-19-56(45)59;1-51(2)47-26-12-13-27-49(47)53(44-23-10-5-11-24-44)50-33-30-42(36-48(50)51)40-19-14-18-39(34-40)41-20-15-25-46(35-41)52(43-21-8-4-9-22-43)45-31-28-38(29-32-45)37-16-6-3-7-17-37;1-51(2)47-24-14-15-25-49(47)53(44-33-28-39(29-34-44)46-23-13-12-22-45(46)38-16-6-3-7-17-38)50-35-30-40(36-48(50)51)37-26-31-43(32-27-37)52(41-18-8-4-9-19-41)42-20-10-5-11-21-42/h3-10,12-14,17-41H,11,15-16H2,1-2H3;2*3-36H,1-2H3
InChIKeyJZDRGHYEYSIXOV-UHFFFAOYSA-N
MW2206.89 g/mol
LogP46.23
Rot. Bonds19

About 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine

3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine (PubChem CID 159066790) has the molecular formula C166H128N6 and a molecular weight of 2206.89 g/mol. Its IUPAC name is 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine.

Molecular Properties

Compound Name3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine
PubChem CID159066790
Molecular FormulaC166H128N6
Molecular Weight2206.89 g/mol
Exact Mass2205.02
IUPAC Name3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine
SMILESCC1(C)c2ccccc2N(c2ccc(-c3ccccc3-c3ccccc3)cc2)c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc21.CC1(C)c2ccccc2N(c2ccc3c(c2)CCCc2ccccc2-3)c2ccc(-c3ccc(N(c4ccc5c(ccc6ccccc65)c4)c4ccc5c(ccc6ccccc65)c4)cc3)cc21.CC1(C)c2ccccc2N(c2ccccc2)c2ccc(-c3cccc(-c4cccc(N(c5ccccc5)c5ccc(-c6ccccc6)cc5)c4)c3)cc21
InChIInChI=1S/C64H48N2.2C51H40N2/c1-64(2)60-20-9-10-21-62(60)66(53-33-36-57-47(38-53)16-11-15-43-12-3-6-17-54(43)57)63-37-28-46(41-61(63)64)42-26-29-50(30-27-42)65(51-31-34-58-48(39-51)24-22-44-13-4-7-18-55(44)58)52-32-35-59-49(40-52)25-23-45-14-5-8-19-56(45)59;1-51(2)47-26-12-13-27-49(47)53(44-23-10-5-11-24-44)50-33-30-42(36-48(50)51)40-19-14-18-39(34-40)41-20-15-25-46(35-41)52(43-21-8-4-9-22-43)45-31-28-38(29-32-45)37-16-6-3-7-17-37;1-51(2)47-24-14-15-25-49(47)53(44-33-28-39(29-34-44)46-23-13-12-22-45(46)38-16-6-3-7-17-38)50-35-30-40(36-48(50)51)37-26-31-43(32-27-37)52(41-18-8-4-9-19-41)42-20-10-5-11-21-42/h3-10,12-14,17-41H,11,15-16H2,1-2H3;2*3-36H,1-2H3
InChIKeyJZDRGHYEYSIXOV-UHFFFAOYSA-N
XLogP46.23
TPSA19.44 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds19
Heavy Atoms172
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5002206.89
LogP ≤ 546.23
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(9,9-dimethyl-7-phenanthren-3-yl-10-phenylacridin-2-yl)-N,N-diphenylaniline
CID 118122536
N-[4-[4-(N-(9,9-dimethyl-7,10-diphenylacridin-2-yl)anilino)phenyl]phenyl]-9,9-dimethyl-N,7,10-triphenylacridin-2-amine;N-[4-[4-(N-[9,9-dimethyl-10-(4-methylphenyl)-7-phenylacridin-2-yl]anilino)phenyl]phenyl]-9,9-dimethyl-10-(4-methylphenyl)-N,7-diphenylacridin-2-amine;N-[4-[4-(N-(9,9-dimethyl-10-naphthalen-1-yl-7-phenylacridin-2-yl)anilino)phenyl]phenyl]-9,9-dimethyl-10-naphthalen-1-yl-N,7-diphenylacridin-2-amine;N-[4-[4-[(9,9-dimethyl-10-phenylacridin-2-yl)-naphthalen-1-ylamino]phenyl]phenyl]-9,9-dimethyl-N-naphthalen-2-yl-10-phenylacridin-2-amine;N-[4-[4-[[9,9-dimethyl-10-(4-phenylphenyl)acridin-2-yl]-naphthalen-1-ylamino]phenyl]phenyl]-9,9-dimethyl-N-naphthalen-2-yl-10-(4-phenylphenyl)acridin-2-amine
CID 159235712
bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline);bis(N-[4-[3-(9H-acridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline);N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,4-diphenylphenyl)-3,4-diphenylaniline;N-[4-[3-(9,9-dimethylacridin-10-yl)phenyl]phenyl]-N-(3,5-diphenylphenyl)-3,5-diphenylaniline;N-(3,4-diphenylphenyl)-3,4-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline;N-(3,5-diphenylphenyl)-3,5-diphenyl-N-[4-[3-(10-phenylphenazin-5-yl)phenyl]phenyl]aniline
CID 158494405
N-[4-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-9,9-dimethyl-N-(4-phenylphenyl)fluoren-2-amine
CID 58489884
N-[4-[9,9-dimethyl-10-(4-phenylphenyl)acridin-2-yl]phenyl]-3-methyl-N-(3-methylphenyl)aniline
CID 89457849
N-(9,9-dimethylfluoren-2-yl)-9,9-dimethyl-N,7,10-triphenylacridin-2-amine
CID 144559421
N-[4-(9,9-dimethyl-10-phenylacridin-3-yl)phenyl]-N,3-diphenylaniline
CID 121258973
6-(9,9-dimethyl-7,10-diphenylacridin-2-yl)-N,N-diphenylnaphthalen-2-amine;N-[4-(9,9-dimethyl-10-phenanthren-2-ylacridin-2-yl)phenyl]-2-methyl-N-(2-methylphenyl)aniline;N,4-diphenyl-N-[4-(7,9,9-trimethyl-10-phenylacridin-2-yl)phenyl]aniline;4-[10-(9-fluorophenanthren-2-yl)-9,9-dimethylacridin-2-yl]-N,N-diphenylaniline
CID 157390516
N-(4-chrysen-5-ylphenyl)-9,9-dimethyl-N-(3-phenylphenyl)fluoren-2-amine
CID 170675737
4-[10-(9-fluorophenanthren-2-yl)-9,9-dimethylacridin-2-yl]-N,N-diphenylaniline
CID 89457920
N-(9,9-dimethylfluoren-2-yl)-N-(3-phenylphenyl)chrysen-2-amine
CID 170139798
7-dibenzofuran-2-yl-9,9-dimethyl-N-phenanthren-3-yl-N-phenyl-10-(4-phenylphenyl)acridin-2-amine
CID 118122889

Frequently Asked Questions

What is the IUPAC name of 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine?
The IUPAC name of 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine (CID 159066790) is 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine.
What is the SMILES notation for 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine?
The canonical SMILES for 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine is CC1(C)c2ccccc2N(c2ccc(-c3ccccc3-c3ccccc3)cc2)c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc21.CC1(C)c2ccccc2N(c2ccc3c(c2)CCCc2ccccc2-3)c2ccc(-c3ccc(N(c4ccc5c(ccc6ccccc65)c4)c4ccc5c(ccc6ccccc65)c4)cc3)cc21.CC1(C)c2ccccc2N(c2ccccc2)c2ccc(-c3cccc(-c4cccc(N(c5ccccc5)c5ccc(-c6ccccc6)cc5)c4)c3)cc21.
What is the InChIKey of 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine?
The InChIKey is JZDRGHYEYSIXOV-UHFFFAOYSA-N. The full InChI is InChI=1S/C64H48N2.2C51H40N2/c1-64(2)60-20-9-10-21-62(60)66(53-33-36-57-47(38-53)16-11-15-43-12-3-6-17-54(43)57)63-37-28-46(41-61(63)64)42-26-29-50(30-27-42)65(51-31-34-58-48(39-51)24-22-44-13-4-7-18-55(44)58)52-32-35-59-49(40-52)25-23-45-14-5-8-19-56(45)59;1-51(2)47-26-12-13-27-49(47)53(44-23-10-5-11-24-44)50-33-30-42(36-48(50)51)40-19-14-18-39(34-40)41-20-15-25-46(35-41)52(43-21-8-4-9-22-43)45-31-28-38(29-32-45)37-16-6-3-7-17-37;1-51(2)47-24-14-15-25-49(47)53(44-33-28-39(29-34-44)46-23-13-12-22-45(46)38-16-6-3-7-17-38)50-35-30-40(36-48(50)51)37-26-31-43(32-27-37)52(41-18-8-4-9-19-41)42-20-10-5-11-21-42/h3-10,12-14,17-41H,11,15-16H2,1-2H3;2*3-36H,1-2H3.
What are the key properties of 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine?
3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine has a molecular weight of 2206.89 g/mol, XLogP of 46.23, 19 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine is sourced from PubChem (CID 159066790), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).